Int J Prevent Med 10 Wei J, Xu H, Davies JL, Hemmings GP (1992) Increase of plasma IL-6 concentration with age in healthy subjects
Decreases in plasma TMAO were associated with BMD loss, irrespective of changes in body weight, diabetes condition, or blood glucose levels
Product access and compounding rules shift over time, so verify source, sterility, concentration, and current rules before any vial-based dosing under clinician supervision. Concentration equals vial milligrams divided by BAC water milliliters
Newer ones such as semaglutide and tirzepatide, broadly known as GLP-1s, have exploded in popularity for weight loss and have shown promise for treating other conditions, such as addictions and neurodegenerative and liver diseases